magnolol has been researched along with acetylcysteine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bae, K; Kim, GD; Lee, SK; Oh, J; Park, HJ | 1 |
1 other study(ies) available for magnolol and acetylcysteine
| Article | Year |
|---|---|
Magnolol inhibits angiogenesis by regulating ROS-mediated apoptosis and the PI3K/AKT/mTOR signaling pathway in mES/EB-derived endothelial-like cells.
Topics: Acetylcysteine; Angiogenesis Inhibitors; Animals; Apoptosis; Biphenyl Compounds; Caspase 3; Cell Differentiation; Cell Line; Embryonic Stem Cells; Endothelial Cells; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; JNK Mitogen-Activated Protein Kinases; Lignans; MAP Kinase Signaling System; Membrane Potential, Mitochondrial; Mice; Mitochondria; Neovascularization, Pathologic; Nitric Oxide Synthase; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Platelet Endothelial Cell Adhesion Molecule-1; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; TOR Serine-Threonine Kinases | 2013 |